CD8A and myeloid sarcoma: T lymphocytes, both CD4+ T cells and CD8+ T cells, take part in the pathological process, and in particular MS is triggered by pathogenic T helper (Th) 17, Th1, and CD8+ autoreactive T lymphocytes directed against myelin components.